Article has no nextliveshere tags assigned

Article has no topics tags assigned

Article has no colleges tags assigned

Article has no audiences tags assigned

Article has no units tags assigned

Contacts are empty

These messages will display in edit mode only.

New York Times: What to expect when a coronavirus vaccine arrives

Audiences are reliving contributions by UC's Albert Sabin as part of historical vaccine talk

An article in today’s New York Times discusses the contributions of UC’s famed doctor Albert Sabin, who developed the live oral polio vaccine.

Albert Sabin in his lab

UC researcher Albert Sabin in his lab. photo/UC Archives

In 1958, “the federal government approved an oral polio vaccine, developed by Sabin’s laboratory in Cincinnati, containing weakened, not inactivated, virus,” states the article. “By the end of that year, polio infections were down 90 percent from 1955 levels. In 1979, the country recorded its last community-transmitted case.

"Today, decades into a global vaccination campaign, polio persists in just three countries. The battle against the disease has been a century-long march. And it has required a sustained commitment to continuing polio vaccination — a commitment now compromised as global polio vaccination efforts have been put on hold to slow the coronavirus’s spread."

Read the complete New York Times article

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.